Ipamorelin5mg

Ipamorelin is a selective growth-hormone secretagogue, meaning it prompts the pituitary to release a clean pulse of growth hormone. What sets it apart in the research is its selectivity: studies show it triggers GH release without meaningfully raising cortisol or prolactin, the off-target hormones that less selective compounds tend to stimulate.

Because it works through the ghrelin-receptor pathway rather than the GHRH pathway, it is commonly studied in growth-hormone-axis protocols where a larger combined GH pulse is the research target. Research interest centers on recovery, sleep, body composition, and bone.

Human studies are few and early, with most evidence coming from animal and laboratory work, so it's treated as an experimental compound rather than an approved therapy. It is not FDA-approved.